Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The therapeutic potential of cannabinoids for movement disorders.
Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair.
Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.
miFRame: analysis and visualization of miRNA sequencing data in neurological disorders.
In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.
Lesional accumulation of CD8(+) cells in sciatic nerves of experimental autoimmune neuritis rats.
EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE).
Gait variability in people with neurological disorders: A systematic review and meta-analysis.
Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.
Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
IL-15-secreting γδT cells induce memory T cells in experimental allergic encephalomyelitis (EAE) mice.
Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases.
Multiple sclerosis at Jordan University Hospital.
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
Full-Length and Fragmented Netrin-1 in Multiple Sclerosis Plaques Are Inhibitors of Oligodendrocyte Precursor Cell Migration.
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation.
Pages
« first
‹ previous
…
575
576
577
578
579
580
581
582
583
…
next ›
last »